Alembic Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,847.72 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.52 per cent from ₹1,876.31 crore. This corresponds to a year-on-year *(YoY) growth of 4.41 per cent.
Operating Profit
Operating Profit stands at ₹203.16 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.55 per cent from ₹249.43 crore. This corresponds to a year-on-year *(YoY) decline of 25.11 per cent.
PBDT
PBDT stands at ₹207.21 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 14.24 per cent from ₹241.62 crore. This corresponds to a year-on-year *(YoY) decline of 20.59 per cent.
Profit Before Tax
Profit Before Tax stands at ₹118.62 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 26.55 per cent from ₹161.50 crore. This corresponds to a year-on-year *(YoY) decline of 38.20 per cent.
Net Profit
Net Profit stands at ₹201.53 crore, reflecting a quarter-on-quarter *(QoQ) increase of 52.73 per cent from ₹131.95 crore. This represents a 28.67 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Alembic Pharmaceuticals Ltd News
Alembic Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Alembic Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Alembic Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Alembic Pharmaceuticals Ltd Financial Reports
Alembic Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Alembic Pharma | -0.98% | 5.88% | 12.82% | 24.54% | -2.26% | -17.46% |
| OneSource Speci. | 0.14% | 7.16% | -9.10% | 18.35% | -7.58% | -17.49% |
| Cohance Life | 0.39% | -0.78% | 6.11% | 47.75% | -12.13% | -53.03% |
| Natco Pharma | -1.25% | 1.85% | -2.01% | -10.47% | 3.01% | -0.18% |
| Jubilant Pharmo | -0.12% | 0.80% | -0.38% | 15.72% | -7.98% | -18.87% |
| Alivus Life | -3.45% | 0.62% | 6.28% | 12.78% | 21.97% | 10.12% |
| Concord Biotech | 0.91% | 0.99% | 11.13% | 26.39% | -1.00% | -26.22% |
Company Info
Company Information
Chairman and MD & CEO : Chirayu R Amin
Independent Director : Pranav N Parikh
Independent Director : K G Ramanathan
Independent Director : Paresh Saraiya
Director & CFO : Rajkumar Baheti
Independent Director : Milin Mehta
Managing Director : Pranav Amin
Managing Director : Shaunak Amin
Independent Director : Archana Hingorani
Company Secretary : Charandeep Singh Saluja